Researchers said Thursday they had successfully tested a Chinese-developed drug against opisthorchiasis, a neglected tropical disease that threatens some 67 million people in Southeast Asia. Tribendimidine is as safe and effective against the tiny worm that causes the disease as the frontline drug, praziquantel, marketed as Biltricide, they reported in a study in Lancet Infectious Diseases.........click for more

Source Web Page: Physorg.com